Qiaodan Jiang1, Weicong Zheng2, Beilei Chen3. 1. Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Wenling Wenling 317500, Zhejiang Province, China. 2. Lithotripsy Center, The First People's Hospital of Wenling Wenling 317500, Zhejiang Province, China. 3. Department of Pulmonary and Critical Care Medicine II, The First People's Hospital of Wenling Wenling 317500, Zhejiang Province, China.
Abstract
OBJECTIVE: This study aimed to investigate the nursing of postoperative lung cancer patients treated withcontinuous positive airway pressure (CPAP). METHODS: A total of 64 lung cancer patients in our hospital were recruited as the study cohort and randomly divided into a CPAP group and a control group. The patients in the CPAP group (n=30) were administered CPAP, while those in the control group (n=34) were given routine low flow oxygen inhalation, a respiratory stimulant, a bronchodilator, antibiotics, antitussives, anti-inflammatories (glucocorticoids), an apophlegmatisant (ambroxol), basic nutritional support, correcting acidosis, etc. Results: The patients in the CPAP group showed a more significant improvement in their blood gas analysis, and they also had better airway patency and secretion cleaning effects compared with those in the control group. One month after the treatment, the patients in the CPAP group had significantly less inappetence, weight loss, electrolyte disturbance, dyspnea, and pulmonary encephalopathy than the patients in the control group. One week after the treatment, the patients in the CPAP group had higher maximum ventilatory volumes (MVV), higher maximum mid-expiratory flows (MMF), higher forced expiratory volumes in 1s/forced vital capacity (FEV1/FVC), higher peak expiratory flows (PEF), and higher total lung capacity (TLC) than the patients in the control group. CONCLUSION:CPAP can significantly improve postoperative dyspnea in lung cancer patients. AJTR
RCT Entities:
OBJECTIVE: This study aimed to investigate the nursing of postoperative lung cancerpatients treated with continuous positive airway pressure (CPAP). METHODS: A total of 64 lung cancerpatients in our hospital were recruited as the study cohort and randomly divided into a CPAP group and a control group. The patients in the CPAP group (n=30) were administered CPAP, while those in the control group (n=34) were given routine low flow oxygen inhalation, a respiratory stimulant, a bronchodilator, antibiotics, antitussives, anti-inflammatories (glucocorticoids), an apophlegmatisant (ambroxol), basic nutritional support, correcting acidosis, etc. Results: The patients in the CPAP group showed a more significant improvement in their blood gas analysis, and they also had better airway patency and secretion cleaning effects compared with those in the control group. One month after the treatment, the patients in the CPAP group had significantly less inappetence, weight loss, electrolyte disturbance, dyspnea, and pulmonary encephalopathy than the patients in the control group. One week after the treatment, the patients in the CPAP group had higher maximum ventilatory volumes (MVV), higher maximum mid-expiratory flows (MMF), higher forced expiratory volumes in 1s/forced vital capacity (FEV1/FVC), higher peak expiratory flows (PEF), and higher total lung capacity (TLC) than the patients in the control group. CONCLUSION: CPAP can significantly improve postoperative dyspnea in lung cancerpatients. AJTR